As of 2025-09-18, the Relative Valuation of Haemonetics Corp (HAE) is 83.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 51.02 USD, the upside of Haemonetics Corp based on Relative Valuation is 63.7%.
The range of the Relative Valuation is 54.24 - 119.33 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 35.2x | 25.6x |
| Forward P/E multiples | 16.5x - 28.9x | 22.7x |
| Fair Price | 54.24 - 119.33 | 83.50 |
| Upside | 6.3% - 133.9% | 63.7% |
| Date | P/E |
| 2025-09-16 | 15.05 |
| 2025-09-15 | 15.15 |
| 2025-09-12 | 15.40 |
| 2025-09-11 | 15.78 |
| 2025-09-10 | 15.83 |
| 2025-09-09 | 16.00 |
| 2025-09-08 | 15.96 |
| 2025-09-05 | 16.04 |
| 2025-09-04 | 15.95 |
| 2025-09-03 | 15.72 |
| 2025-09-02 | 15.79 |
| 2025-08-29 | 16.09 |
| 2025-08-28 | 16.03 |
| 2025-08-27 | 16.23 |
| 2025-08-26 | 16.29 |
| 2025-08-25 | 16.29 |
| 2025-08-22 | 16.63 |
| 2025-08-21 | 15.92 |
| 2025-08-20 | 16.06 |
| 2025-08-19 | 16.02 |
| 2025-08-18 | 15.67 |
| 2025-08-15 | 15.85 |
| 2025-08-14 | 15.44 |
| 2025-08-13 | 15.89 |
| 2025-08-12 | 15.41 |
| 2025-08-11 | 15.48 |
| 2025-08-08 | 15.93 |
| 2025-08-07 | 16.41 |
| 2025-08-06 | 22.35 |
| 2025-08-05 | 22.45 |
| 2025-08-04 | 22.51 |
| 2025-08-01 | 22.06 |
| 2025-07-31 | 21.84 |
| 2025-07-30 | 22.38 |
| 2025-07-29 | 22.28 |
| 2025-07-28 | 22.02 |
| 2025-07-25 | 22.18 |
| 2025-07-24 | 21.90 |
| 2025-07-23 | 21.99 |
| 2025-07-22 | 21.89 |
| 2025-07-21 | 21.76 |
| 2025-07-18 | 21.40 |
| 2025-07-17 | 21.67 |
| 2025-07-16 | 21.95 |
| 2025-07-15 | 22.01 |
| 2025-07-14 | 22.61 |
| 2025-07-11 | 22.28 |
| 2025-07-10 | 23.06 |
| 2025-07-09 | 22.87 |
| 2025-07-08 | 22.41 |